Home » Newsletters » BioWorld Asia

BioWorld Asia

March 17, 1999

View Archived Issues

Synsorb Biotech Acquiring Oncolytics, Reovirus Drugs

European Parliament Backs Orphan Drug Development

Xenova Seeking Partners, Buyers For Subsidiaries

Transghne Begins Phase II Trials Of Lung-Cancer Drug

Canadians Launch Resource For DNA Sequence Retrieval

Microscience Granted Patents For Finding Virulence Genes

Vanguard Medica Reduces Losses Through Elan Deal

Former Cortecs Executive Gets Dismissal Settlement

Pharming Wins Backing Of Belgian Government

Cantab Reports Earnings, Plans Phase II Studies

Other News To Note

Scientists Start Company Using Proteome Analysis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...